Hoxha, Ariela. 2026. “CO097 | IMPACT OF THE 2023 ACR EULAR ANTIPHOSPHOLIPID SYNDROME CRITERIA IN 1200 WOMEN WITH PRIOR OBSTETRIC ANTIPHOSPHOLIPID SYNDROME: J. Alijotas-Reig1|2|3, E. Esteve-Valverde4, L. Saez-Comet5, A. Anunciacion-Llunell3, R. Ferrer-Oliveras6, E. Lefkou7, A. Mekinian8, C. Belizna9, A. Hoxha10, A. Tincani11, L. Marozio12, G. Espinosa13, S. De Carolis14, S. Udry15, J.O. Latino15, E. Llurba16, C.B. Chighizola17|18, M. Gerosa19, V. Pengo20, K. Lundelin21, P. Rovere-Querini22, V. Canti22, K. Mayer-Pickel23, T. Reshetnyak24, S. Tabacco25, L. Stojanovich26, B.A. Gonçalves27, S. Morales-Perez1, F. Miro-Mur3 | 1Department of Medicine, Universitat Autonoma De Barcelona, Spain; 2Systemic Autoimmune Disease Unit, Department of Internal Medicine, Vall d’Hebron University Hospital, Spain; 3Systemic Autoimmune Diseases Research Unit, Vall d’Hebron Institut De Recerca, Barcelona, Spain; 4Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Sant Camil, Consorci Sanitari Del Garraf, Barcelona, Spain; 5Department of Internal Medicine, Hospital Universitario Miguel Servet, Zaragoza, Spain; 6Obstetrics Department, High-Risk Unit, Hospital Universitario Quironsalud, Barcelona, Spain; 7Haematology Unit, Hippokration Hospital of Thessaloniki, Greece; 8AP-HP, Hopital Saint-Antoine, Service De Medecine Interne and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Sorbonne Universites, Paris, France; 9Vascular and Coagulation Department, University Hospital Angers, Angers, France; 10Internal Medicine Unit, Thrombotic and Bleeding Disorder Center, University of Padua, Padova, Italy; 11Department of Clinical and Experimental Sciences, University of Brescia, Spedali Civili, Brescia, Italy; 12Department of Obstetrics and Gynaecology, Universita Di Torino, Torino, Italy; 13Systemic Autoimmune Diseases Service, Hospital Clínic, Universitat De Barcelona, Barcelona, Spain; 14Department of Gynaecology, Gemelli Hospital, Catholic University, Roma, Italy; 15Autoimmune, Thrombophilic Diseases and Pregnancy Division, Dr. Carlos G. Durand Hospital, Buenos Aires, Argentina; 16Obstetrics and Gynaecology Department, High-Risk Unit, University Hospital De La Santa Creu I Sant Pau, Barcelona, Spain; 17Department of Clinical Science and Community Health, University of Milano, Milano, Italy; 18Unit of Pediatric Rheumatology, ASST G. Pini-CTO, Milano, Italy; 19Division of Rheumatology, Department of Clinical Sciences and Community Health, University of Milano, Milano, Italy; 20Cardiology Unit, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padova, Italy; 21Department of Pediatrics, Faculty of Medicine, University of Turku, Turku, Finland; 22Internal Medicine and Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milano, Italy; 23Department of Obstetrics, Medical University of Graz, Graz, Austria; 24Department of Systemic Rheumatic Disease, V. A. Nasonova Research Institute of Rheumatology, Moscow, Russia; 25Department of Gynecology, Obstetrics and Urology, Sapienza University of Roma, Roma, Italy; 26University Medical Center, University of Belgrade, Belgrade, Serbia; 27Department of Internal Medicine, Hospital Sant Joan Despí Moises-Broggi, Barcelona, Spain”. Bleeding, Thrombosis and Vascular Biology 5 (s3). https://doi.org/10.4081/btvb.2026.799.